BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)

6.10USD +3.92% (+0.23)

Over 6M: +1120.0%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

2 4 6
Mar Apr May Jun Jul Aug Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Net Income: -113.9K Q4 '21 — Net Income: -120.7K Q1 '22 — Net Income: -132.4K Q2 '22 — Net Income: -115.8K Q3 '22 — Net Income: -122.6K Q4 '22 — Net Income: -114.7K Q1 '23 — Net Income: -130K Q2 '23 — Net Income: -113.9K Q3 '23 — Net Income: -113.6K Q4 '23 — Net Income: -114.4K Q1 '24 — Net Income: -130.8K Q2 '24 — Net Income: -114.4K Q3 '24 — Net Income: -122K Q4 '24 — Net Income: -123.2K Q1 '25 — Net Income: -935.5K Q2 '25 — Net Income: -122.8K Q3 '25 — Net Income: -115.9K Q4 '25 — Net Income: -118.6K Q1 '26 — Net Income: -102.4K Q2 '26 — Net Income: 238.7K -750K -500K -250K 0 250K
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.5
Oper. margin -261.8%
ROIC -1.6%
Gross margin 24.5%
ROCE -2.0%
Asset turnover 0.0074×
Accruals —
Capex / sales —
EBITDA margin —
FCF margin —
OCF / EBIT —
OCF margin —
OE margin —
Profit margin —
ROA —
ROE —
SBC / sales —

2 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

1.0
EV/Sales 11513.9×
EV/GP 46948.5×
P/B 88.9×
P/C 666608.9×
Div. yield —
EV/EBIT —
EV/OE —
FCF yield —
Fwd P/E —
P/E —
PEG —

1 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

6.8
RPO / sales —
RPO growth —
Segment HHI —

1 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.5
Current ratio 25.4×
ND/EBITDA 1.5e-06
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 25.4×
Cash / Debt —
Cash runway —
F-score —
Interest cover —
Payout —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

6.8
Sales/sh Y/Y +9.0%
Sales Q/Q -100.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Shares change —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.